Concepedia

Publication | Open Access

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

DOIFull Paper Access

2K

Citations

32

References

2017

Year

Hagop Kantarjian, Anthony S. Stein, Nicola Gökbuget, Adele K. Fielding, Andre C. Schuh, Josep‐María Ribera, Andrew H. Wei, Hervé Dombret, Robin Foà, Renato Bassan,
New England Journal of Medicine

Abstract

Treatment with blinatumomab resulted in significantly longer overall survival than chemotherapy among adult patients with relapsed or refractory B-cell precursor ALL. (Funded by Amgen; TOWER ClinicalTrials.gov number, NCT02013167 .).

References

YearCitations

Page 1